Department of Geriatrics, The Affiliated Hospital 2 of Nantong University, Nantong, Jiangsu, China.
Department of Emergency, The Affiliated Hospital 2 of Nantong University,, Nantong, Jiangsu, China.
Medicine (Baltimore). 2023 Feb 22;102(8):e32874. doi: 10.1097/MD.0000000000032874.
Frailty can change the prognosis and treatment approach of chronic diseases. We, therefore, conducted this study to explore the relationship between frailty syndrome and blood pressure variability in the elderly. The clinical data of 150 elderly patients with debilitating syndrome admitted to the neurology department of our hospital from May 2021 to May 2022 were selected, and they were grouped according to Fried debilitation scale and divided into 50 cases each in the debilitation group, pre-debilitation group, and no-debilitation group. The general data, co-morbidities, medications, and biochemical indexes were collected. The 24-hour ambulatory blood pressure monitoring was performed in each group, and the mean systolic blood pressure, diastolic blood pressure, nocturnal systolic load value, and diastolic load value were analyzed to determine the relationship between blood pressure variability and senile frailty. Serum albumin (ALB) and high-density lipoprotein were significantly lower in the debilitated and pre-debilitated groups than in the non-debilitated group (P < .05). Multivariate logistic regression analysis revealed that age (odds ratio [OR]: 3.910, 95% confidence intervals [CI]: 2.021-5.402) was a risk factor for frailty in the elderly, and serum ALB (OR: 0.656, 95% CI: 0.110-0.960) and HDL (OR: 0.581, 95% CI: 0.237-0.944) were protective factors for frailty in the elderly. Age, type of medication taken, co-morbidities, serum ALB, and HDL are influencing factors of debilitating syndrome. Serum ALB and HDL are protective factors against debilitating syndrome in the elderly. Age is an independent risk factor of debilitation in the elderly and increased fluctuation of blood pressure in the elderly can increase their risk of developing debilitating syndrome.
衰弱可以改变慢性病的预后和治疗方法。因此,我们进行了这项研究,以探讨老年衰弱综合征与血压变异性之间的关系。选取 2021 年 5 月至 2022 年 5 月我院神经内科收治的 150 例衰弱综合征老年患者的临床资料,根据 Fried 衰弱量表进行分组,分为衰弱组、衰弱前期组和非衰弱组各 50 例。收集各组一般资料、合并症、用药及生化指标,行 24 h 动态血压监测,分析平均收缩压、舒张压、夜间收缩压负荷值、舒张压负荷值与老年衰弱的关系。衰弱组和衰弱前期组血清白蛋白(ALB)、高密度脂蛋白(HDL)均明显低于非衰弱组(P<0.05)。多因素 logistic 回归分析显示,年龄(比值比[OR]:3.910,95%置信区间[CI]:2.0215.402)是老年衰弱的危险因素,血清 ALB(OR:0.656,95%CI:0.1100.960)和 HDL(OR:0.581,95%CI:0.237~0.944)是老年衰弱的保护因素。年龄、用药类型、合并症、血清 ALB 和 HDL 是衰弱综合征的影响因素。血清 ALB 和 HDL 是老年衰弱综合征的保护因素。年龄是老年衰弱的独立危险因素,老年血压波动增加会增加其衰弱综合征的发病风险。